Mild cognitive impairment: conceptual issues and structural and functional brain correlates

Andrew J Saykin1, Heather A Wishart

  • 1Brain Imaging Laboratory, Department of Psychiatry, Dartmouth Medical School, Lebanon, NH 03756-0001, USA. Andrew.J.Saykin@dartmouth.edu

Seminars in Clinical Neuropsychiatry
|February 5, 2003
PubMed

Insights

Mild cognitive impairment (MCI) is common in older adults and may lead to dementia. Early detection and intervention are key to potentially delaying or preventing Alzheimer's disease progression.

Area of Science:

  • Gerontology
  • Neurology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is a significant risk factor for dementia in the elderly.
  • Early detection and intervention strategies are crucial for managing potential progression to Alzheimer's disease.
  • Understanding the neurobiology of MCI is vital for developing effective treatments.

Purpose of the Study:

  • To review the current understanding of mild cognitive impairment (MCI).
  • To discuss the diagnosis and assessment of memory complaints in older adults.
  • To summarize recent neurobiological findings related to MCI.

Main Methods:

  • Literature review of conceptualization and diagnosis of MCI.
  • Analysis of assessment methods for memory deficits in the elderly.
  • Synthesis of recent neuroimaging and neurochemical research on MCI.

Main Results:

  • MCI is characterized by cognitive deficits beyond normal aging but not meeting dementia criteria.
  • Assessment involves evaluating memory complaints and objective deficits.
  • Neurobiological research highlights neurochemical, structural, and functional brain changes in MCI.

Conclusions:

  • Accurate conceptualization and diagnosis of MCI are essential for timely intervention.
  • Comprehensive assessment of cognitive function is necessary for identifying individuals at risk.
  • Ongoing research into the neurobiological underpinnings of MCI is critical for future therapeutic development.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...